Research
Metabolic adaptation
GLP-1 RA use was associated with significantly reduced risk of revision at 10 years in the 25.0 to 29.9 BMI group.
Consideration of GLP-1 RA may improve long-term surgical outcomes in patients with lower BMI.
StrongSupportsmedium confidence
At 10 years, GLP-1 RA use was associated with significantly reduced risk of revision in the 25.0 to 29.9 (HR 0.79, P =0.046) BMI group.
Why this rating
Based on a large retrospective cohort study.
Source
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Complications Following Thoracic and/or Lumbar Spinal Fusion for Degenerative Spine Disease
Arman Kishan et al. · Spine · 2025
cohort · n=291677Cited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →